Zyprexa & Risperdal 2: The Breast Cancer Link That Could Ignite the Next Mass Tort
The pharmaceutical litigation landscape has seen its share of blockbuster cases—from opioid multidistrict litigations to…
Mass Torts in 2025: A Legal Landscape in Flux
As 2025 unfolds, the world of mass tort litigation shows no signs of slowing down….
The PFAS Contamination Crisis: A Deep Dive into the Mass Tort Litigation and Its Implications
Per- and polyfluoroalkyl substances (PFAS), often referred to as “forever chemicals,” have become a focal…
The Ultra-Processed Foods Lawsuit: A Must-Know Update for Mass Tort Lawyers
Ultra-processed foods (UPFs) have become a cornerstone of modern diets, but their convenience comes at…
Understanding the BioZorb Litigation: A Growing Legal Battle for Plaintiff Attorneys
What is BioZorb? The BioZorb litigation is shaping up to be one of the most…
The Role of Technology in Optimizing Workers’ Compensation Lead Generation
The process of generating and managing workers’ compensation leads has undergone a significant transformation with…
How to Build a Referral Network for Mass Tort Cases
Mass tort cases often involve a large number of claimants seeking justice for harm caused…
Why High-Quality Auto Accident Leads Matter: A Data-Driven Approach
In the fast-paced world of personal injury law and insurance claims, securing quality auto accident…
Depo-Provera: Insights for Lawyers in the Evolving Litigation Landscape
The legal landscape surrounding Depo-Provera litigation is complex and still evolving, but understanding key trends…
Best Practices for Screening Roundup Claimants: Ensuring Quality and Preventing Fraud in Mass Tort Cases
A Growing Need for High-Quality Roundup Claimants As Roundup litigation continues to unfold, the volume…